Revolutionary gene-editing therapy for sickle cell approved

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder hope of a cure. Professor of paediatric sickle cell disease David Rees welcomed the decision, calling it a "momentous day". Report by Kennedyl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn